Epidemiologia astmy w Polsce z podziałem na regiony wiejskie i miejskie na podstawie danych dotyczących udzielanych świadczeń zdrowotnych
Introduction
Asthma is a chronic inflammatory disease of the respiratory tract. This illness is a significant social and economical problem due to its symptoms, which significantly impact the quality of life, and frequently also the life expectancy of patients, but also due to its prevalence: in accordance with epidemiological data up to 10% of Polish population suffers from asthma (*ECAP study). The definition of asthma, which was first published in the GINA document in 1993 is constantly modified as the knowledge on the complex pathogenesis and phenotypes of the illness is being complemented. The definition currently in force describes asthma as: "heterogeneous disease, usually characterized by chronic airway inflammation".
It is defined by the history of respiratory symptoms such as wheeze, shortness of breath, chest tightness, and cough that vary over time and in intensity, together with variable expiratory airflow limitation" (*GINA2014).
This definition shows clearly that the diagnosis of asthma is a clinical diagnosis, in practice not based on objective criteria. This results in the diagnostics of this illness being difficult and highly dependent on the experience and knowledge of the medical practitioner [1, 2] . Additionally the complicated pathogenesis of the disease, the variation of its symptoms, the geographic diversification of its occurrence, the impact of age, method of disease treatment (disease control) and co-existing diseases result in a frequently inaccurate epidemiological assessment, resulting from either overdiagnosing or, as frequently, underdiagnosing the incidence of disease.
Health services in Poland are financed by the National Health Fund (NFZ), pursuant to the Act [3] and the Regulation of the Minister of Health resulting thereof [4] . Treatment of respiratory tract diseases is performed within a framework of a health services provision contract. The rules of organisation, financing and settling of the services are in accordance with the NFZ President's Regulations [5] . Due to the organisation of health care in Poland, asthma is most frequently diagnosed by primary health care physicians and by pulmonary pulmonary medicine or allergology specialists. Most frequently these diagnoses are treated as initial and requiring confirmation, established as observation for asthma.
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Epidemiology of asthma
It is estimated that over 300 million people suffer from asthma worldwide -depending on the study the data indicate the presence of the disease among 1−18% of the general population [6−11] . It is estimated that solely in Europe approx. 30 million people are treated for asthma [8] . Most frequently the course of asthma is mild or moderate. This means that full control is obtained with the use of small or moderate doses of drugs which modify the course of the disease. However in approximately 5% of patients heavy asthma is present, which requires the use of high doses of drugs. This is frequently connected to occurrence of adverse effects (frequently serious), while not always leading to the management of symptoms. This results in significant increase of treatment costs, resulting from the increase of the number of unplanned visits, emergency (ER) visits, hospitalisations, and also from the feeling of being sick, absenteeism at work and many other indirect costs. It is estimated that almost 95% of all resources assigned to asthma therapy is used for the treatment of this group (5% of patients).
Reaching further into pharmacoeconomic data it is estimated that the treatment of asthma accounts for 1% to 2% of expenses for the treatment of chronic diseases and 15 million of DALYs (disability-adjusted life years). Although in developed countries the incidence rate has reached a plateau, in countries where these indicators where on a low level so far a significant increase of incidence rate can be observed currently [12, 13] .
Asthma is a serious health and social problem, also in Poland. The epidemiological data indicate that the problem of asthma concerns approximately 4 million people in Poland, whereas almost 70% of them have no diagnosis and are not aware of their illness, and on the other hand in 39% of persons who declared the diagnosis of asthma in a survey the diagnosis was negatively verified (overdiagnosis of asthma) [14] . At the same time in the group of allergic diseases asthma is first in the ranking of absence caused by disease, of hospitalisation, disability and death [9] . Approximately 1500 patients die annually in Poland due to asthma complications. The character of the disease, that is, the chronic or recurrent symptoms of airway limitation mean that asthma has a significant impact also on factors such as quality of life, efficiency in work, absences caused by disease, frequency of hospitalisation or social activity. This results in high economic and social costs, the assessment of which is difficult.
Although the assessment of costs performed as a part of epidemiological studies is accurate, it is also expensive and possible to be conducted only as a part of a certain section of population. The high costs of these studies prevent them from being repeated in intervals which would enable the assessment of trends over time. For this reason attempts at using secondary sources of information, such as disease registries, data on temporary inability to work, hospital statistics or outpatient treatment statistics for the studies of direct and indirect costs of asthma have been made. Although these data have some error resulting from the inaccuracy of diagnoses, incompleteness of data or difficulty in establishing the population exposed to risk, they do enable a much wider assessment: it is possible not only to assess the full population which inhabits the given area, but also to observe changes and trends over time, on which the aforementioned error should have no significant impact. Thus one may assume that the use of data sources concerning the use of reimbursed medical products, the use of health care services, such as medical consultation, ER visits or hospitalisations and information concerning social costs of asthma (medical leave -ZUS social security databases) may enable more complete assessment of treated population, and as a consequence the monitoring of asthma incidence rate. Complex multivariate analysis should also enable establishing the dynamics of asthma incidence rate and establishing the factors which may influence the occurrence of the disease, its clinical picture (phenotype) and its course.
So far only few studies were carried out on the epidemiology of asthma in Poland. One of them -PMSEAD (acronym The Polish Multicentre Study of Epidemiology of Allergic Diseases) (22), was designed to obtain estimates representative of the entire Polish population to assess asthma prevalence and risk factors. It was conducted in 11 regions of Poland, each of which was divided to three parts and one part was a rural area. In another big epidemiological study named ECAP a single rural area (2055 surveyed persons) was compared with eight urban areas (cities with population exceeding 100,000 -15,562 surveyed persons). Significant disparity between the study population and the population residing in Poland (rural population is approximately 40% of the population of Poland) may be a source of significant error in both studies, just like a relatively small cohort compared to the country population.
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Currently the data concerning the health care services performed for patients which are delivered by the service providers to the National Health Fund province Departments and collected by the National Health Fund enable the collective analysis of the population of asthma patients in Poland.
The work has described the results of asthma patients' data analysis in the years 2008-2012. The following were estimated: 1. Number of asthma patients, depending on whether the area is urban or rural. 2. Prevalence indicator (per 10,000 inhabitants), taking into account the type of commune, divided by province. 3. Prevalence indicator (per 10,000 inhabitants), taking into account the type of commune. 4. Prevalence indicator (per 10,000 inhabitants), divided by province.
Material and methods
The asthma prevalence database was constructed based on the data reported to NFZ by the service providers. The data of patients for whom ICD-10: J45.X -asthma code was reported was selected from the IT systems which store the information on patients reported in settlement reports. The study used the following data from the data reported in statistical reports: a) unique patient identifier (PESEL number), b) diagnosis (ICD-10 code) and c) residence identifier (commune code).
PESEL number and the diagnosis code enable rather accurate estimation of the number of asthma patients. The place of residence in turn enables identification of the type of commune. The lack of data applies to cases where services were provided to homeless people, for example. In the studied period the share of unidentified data was small and statistically insignificant and amounted to an average of 0.28% (respectively: 2008 -0.25%; 2009 -0.30%; 2010 -0.27%; 2011 -0.29% and 2012 -0.31%). The data was collected from the databases using SQL tools, using a filter in accordance with the accepted scope of ICD-10 diagnoses. The analysis was conducted using Excel and Statistica 10 tools, using a negative binomial regression model. The demographic data was collected from the Central Statistical Office website [15] .
The analysis of the asthma incidence rate trends in Poland calculated based on the health services provided to the patients was compared to the results of obtained studies, in which the following protocols were used: International Study of Asthma and Allergies in Childhood (ISAAC) and European Community Respiratory Health Survey (ECRHS).
Results
The population of asthma patients in Poland during the years 2008−2012 depending on sex was established in Table 1 .
In the year 2009 a significant increase of the number of patients with asthma was observed compared to the previous years, whereas after 2009 the number of patients with a diagnosis of asthma remained at a relatively constant level. A significant increase of the predominance of women among asthma patients during the last years can be noticed: from 107% in 2008 to almost 115% in 2012 (the F:M ratio).
The population of asthma patients in Poland during the years 2008-2012 depending on the place of residence, with an additional division into asthma diagnosis subgroups: J45.0 -predominantly allergic asthma, J45.1 -nonallergic asthma, J45.8 -mixed asthma and J45.9 -unspecified asthma was established in Table  2 . Since approximately 40% of the population inhabits rural areas and 60% -urban areas, Similarly to the previous chart a significant increase of the number of asthma patients compared to the previous year could be observed in 2009. A higher precision in the provision of asthma aetiology information can be noticed since 2011: the number of J.45 diagnoses is decreased compared to J.45.x (unspecified, mixed, nonallergic or predominantly allergic asthma). The observation that regardless of the studied year and diagnosis the incidence rate remains constant: approximately 55−57% for urban areas and approximately 43−45% for rural areas is rather interesting. The nonallergic asthma, which is much more frequently diagnosed in cities than in rural areas: 63:37 is a single exception. The use of a corrected incidence rate enables stating that the number of patients in urban areas is higher (by approximately 10%) from the number of patients in rural areas (Table 3) . The province with the highest prevalence indicator is the Świętokrzyskie province (13) (years 2008−2011) and Wielkopolskie province (15) in 2012. The lowest indicator was noted in the Podlaskie province (10) in all the years included in the study. The marked trend line indicates a similar behaviour of the incidence rate regardless of the region (similar gradient of the trend curve). The diagram presented on Figures 2 demonstrate that the average value of prevalence indicator for rural areas is significantly lower than for urban areas, which corresponds to the results obtained by other studies. This situation may be caused by the way of living of the urban inhabitants, that is more sterile living conditions, exaggerated hygiene or higher environmental pollution in urban areas.
The highest average value of prevalence in urban areas occurs in the Świętokrzyskie province, which was demonstrated in Table 2 . The lowest values are the Podlaskie and Lubuskie provinces. For the rural areas the largest indicator was noted in the following provinces: Świętokrzyskie, Wielkopolskie, Śląskie and Małopolskie, and the lowest one in Podlaskie province (Fig. 3) .
Discussion and conclusions
The second half of the 20 th century is the period of significant increase of incidence of allergic diseases, which are currently one of the largest public health problems [16] . Asthma is an important allergic disease, due to, among others, generation of relatively high social costs. This is why epidemiological studies concerning asthma incidence are so important. Conducting them is difficult, however, due to the aforementioned problems with asthma diagnosis, varying course or different phenotypes of the disease. Epidemiological studies of this disease may use different sources of data listed below: 1. Self-reported data questionnaires, where the patient enters information on key symptoms of asthma. These questionnaires are usually prepared for widely conducted clinical www.pneumonologia.viamedica.pl Depending on the used source of information data on asthma prevalence differ significantly. In a prospective study conducted on a group of children in Denmark, which has compared the 3 assessment methods listed above, prevalence was estimated at 32% based on prescription data, self-reported data questionnaires enabled the diagnosis of the disease in 12% of the population, whereas hospitalisation registries diagnosed asthma in only 6.6%. Moreover, the combination of the three methods enabled the averaging of the prevalence on a level of only 3.6%, which means that the groups established using various methods mostly do not overlap: it was established that these methods are significantly different, as confirmed by a low kappa coefficient (0.21−0.38) [17] . It seems that the method of formulating the questions in the questionnaires may have an impact on these differences. The questions in the ISAAC study turned out to be more efficient. They concentrated not on a previous diagnosis, but on the symptoms and events, such as, e.g. previous hospitalisation for asthma (in the Denmark study one of the questions was: "did a doctor diagnose the child with asthma at any time previously?").
Our data coming from disease registries are also subject to errors mainly associated with inaccuracy of diagnoses: population diagnosed with asthma may involve not only asthma but also ACOS (Asthma/COPD Overlap symptom), COPD (Chronic Obturatory Pulmonary Disease) and some other disorders. Other problems include incompleteness of data or difficulty in establishing the population exposed to risk.
Key role in the epidemiology of asthma was played by two study projects: International Study of Asthma and Allergies in Childhood (ISAAC) and European Community Respiratory Health Survey (ECRHS). The data obtained from them not only supplemented the knowledge on the causes of asthma and other allergic diseases, but became the initial point for further epidemiological studies thereof. The ISAAC study has established asthma incidence differences of up to 15 times between various centres. The ECRHS study (concerning persons aged between 20 and 44 and conducted in 48 centres from 22 countries) also demonstrated the existence of geographical differences in the frequency of occurrence of asthma. It was most rarely diagnosed in Greece and Estonia (2%), and most frequently in Great Britain (8.4%) [18] .
The first epidemiological study of asthma in Poland involving rural areas was PMSEAD published as early as in 2007 (22). The main advantage of this study, as compared to those conducted according to the ISAAC or ECRHS protocols, is that it was based on a sample of population living in different parts of the country. Particular emphasis was placed on proper diagnosis and www.pneumonologia.viamedica.pl selection of a wide range of patients aged 3 to 80 years from both urban and rural environment. It was the first epidemiological study confirming the existence of a strong relationship between increased prevalence of asthma and living in areas with higher black smoke pollution. However study cohort was relatively small due to the study design (19, 000) . In 2003 Samoliński's team conducted the pilot studies in Poland which indicated that the problem of allergic diseases applies to approximately 25% of Poles.
The same team of experts has implemented in the years 2006−2008 a cross-sectional epidemiological study, ECAP (Epidemiology of Allergic Diseases in Poland). It's results indicate that the symptoms of asthma are present in 19.3% of children in the age of 6−7 years, in 10.2% children in the age of 13−14 years and in 12.4% of adults in the age of 20−44 years (average of 13.6%). At the same time a significant difference could be observed in the frequency of occurrence of asthma between urban centres (on average 14%) and rural areas (on average 9.1%). The declared asthma (based on a survey study) was diagnosed in 4.4% of children in the age of 6−7 years, 6.2% of children in the age of 13−14 years and in 4% of adults (on average 4.6%, that is 1.7 million persons). Here also significant differences between urban areas (average 4.8%) and rural areas (average 2.9%). Similar conclusions were obtained by Kulus in his study, which estimates asthma to be twice more frequently present in Warsaw than in Polish villages (22% compared to 11.4%) [19] . Also Kuna, referring to the results of studies conducted by Kupryś-Lipińska et al. within the area of Łódzkie province indicated that asthma is present in 18.4 percent of urban children and 6 percent of children living in rural areas. Similar proportions are present in the adult population: 13.2% of asthmatics in urban areas and 4.2% in rural areas [20, 21] .
In addition, in 2008 NFZ introduced funding of benefits associated with the diagnosis of the disease. This introduction of Diagnosis-Related Group (DRG) system resulted in improving the quality of data transmitted by hospitals. After the initial period of the increase in the number of reported patients in a specific group of diagnoses reporting of data has been stabilizing.
To summarise epidemiological observations it should be emphasised that there is a significant difference in asthma prevalence depending on the region: urban vs rural. The average indicator of prevalence per 10,000 inhabitants for urban areas in the years 2008−2012 amounted to 306.8 patients, with a prevalence for rural areas at a level of 250.9 patients. This indicates that for the studied period the average ratio of urban areas/ rural areas prevalence indicators is 1.22. The highest difference occurred in 2008 (urban/rural = 1.31), reaching a stable value of 1.23 in the next years. Analysing the prevalence value divided by regions the highest prevalence for urban regions occurs in the Świętokrzyskie province (indicator = 395.47; Fig. 3 ), and this value is stable over the entire studied period. Only for 2012 a similarly high value is present in the Wielkopolskie province (indicator = 398.33). In case of rural areas a high value of averaged value of the morbidity indicator is present in multiple provinces: Świę-tokrzyskie (indicator = 301. 
Conclusions
The results of analysis conducted on data concerning the health services provided to asthma patients overlap with the data from previous studies conducted in Poland and worldwide. Thus it seems that this data may be confirmed in the future for epidemiological studies of asthma.
